Results

Total Results: 1,933 records

Showing results for "treatments".

1. Final Research Plan: Glaucoma: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/glaucoma-october-2022
   August 13, 2021 - What are the effects of medical treatments for open-angle glaucoma versus placebo or no treatments on … What are the harms of medical treatments for open-angle glaucoma versus placebo or no therapy? … What are the harms of newly FDA-approved medical treatments versus older medical treatments? … or medical treatment? … , surgery, non-FDA approved therapies, therapies not commonly used as first-line therapy in U.S. practice

2. Final Research Plan: Screening for Glaucoma | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/glaucoma-screening-adults-older-adults
   August 13, 2021 - What are the effects of medical treatments for open-angle glaucoma versus placebo or no treatments on … What are the harms of medical treatments for open-angle glaucoma versus placebo or no therapy? … What are the harms of newly FDA-approved medical treatments versus older medical treatments? … or medical treatment? … , surgery, non-FDA approved therapies, therapies not commonly used as first-line therapy in U.S. practice

3. Final Research Plan: Screening for Primary-Angle Glaucoma | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/primary-angle-glaucoma-screening
   August 13, 2021 - What are the effects of medical treatments for open-angle glaucoma versus placebo or no treatments on … What are the harms of medical treatments for open-angle glaucoma versus placebo or no therapy? … What are the harms of newly FDA-approved medical treatments versus older medical treatments? … or medical treatment? … , surgery, non-FDA approved therapies, therapies not commonly used as first-line therapy in U.S. practice

4. Final Research Plan: Primary Open-Angle Glaucoma: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/primary-open-angle-glaucoma-screening
   June 04, 2020 - What are the effects of medical treatments for open-angle glaucoma versus placebo or no treatments on … What are the harms of medical treatments for open-angle glaucoma versus placebo or no therapy? … What are the harms of newly FDA-approved medical treatments versus older medical treatments? … or medical treatment? … , surgery, non-FDA–approved therapies, therapies not commonly used as first-line therapy in U.S. practice

5. Comparative Effectiveness of Treatments for Open-Angle Glaucoma: A Systematic Review for the USPSTF (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/kHRX4aX5V_GKoygGAeejhb
   February 01, 2013 - Type of treatment does not influence QOL Among medical treatments, patients prefer the treatment that … The 3 systematic reviews provide high strength of ev- idence that decreasing IOP by medical therapies … Of the large studies evaluating medical therapy for glaucoma, both the Ocular Hypertension Treatment … An Evaluation of Therapeutic Noninferiority of 0.005% Latanoprost Ophthal- mic Solution and Xalatan in … or study medications as primary or secondary treatment or as add-ons to other therapy.

6. Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening
   February 15, 2013 - The 3 systematic reviews provide high strength of evidence that decreasing IOP by medical therapies or … Of the large studies evaluating medical therapy for glaucoma, both the Ocular Hypertension Treatment … An evaluation of therapeutic noninferiority of 0.005% latanoprost ophthalmic solution and Xalatan in … or study medications as primary or secondary treatment or as add-ons to other therapy. … patient QOL Type of treatment does not influence QOL Among medical treatments, patients prefer the treatment

7. Archived: Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening-2013
   February 15, 2013 - The 3 systematic reviews provide high strength of evidence that decreasing IOP by medical therapies or … Of the large studies evaluating medical therapy for glaucoma, both the Ocular Hypertension Treatment … An evaluation of therapeutic noninferiority of 0.005% latanoprost ophthalmic solution and Xalatan in … or study medications as primary or secondary treatment or as add-ons to other therapy. … patient QOL Type of treatment does not influence QOL Among medical treatments, patients prefer the treatment

8. Final Research Plan: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication
   May 27, 2021 - What is the average treatment duration in persons who start HT for menopausal symptoms? … Localized (nonsystemic) treatments such as rings, creams, or gels; contraceptives; other hormones; treatments … of menopausal symptoms such as over-the-counter preparations or compounded bioidentical therapies that … , progesterone only therapy, androgen therapy, and testosterone therapy; nonsystemic treatments are not … , androgen therapy, and testosterone therapy are not approved as HT in postmenopausal persons.

9. Draft Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/prostate-cancer-screening-adults
   October 12, 2023 - (i.e., what percentage of men initially choose active surveillance or watchful waiting vs. curative treatments … such as surgery, radiation, or ablative therapy)?     … prostatectomy, including different surgical techniques, such as nerve sparing, robotics) Radiation therapy … (external beam radiation therapy, proton beam therapy, brachytherapy) Cryosurgery/high-intensity focused … ultrasonography/other focal ablative therapies Active surveillance ‡ Watchful waiting ‡ KQs

10. Final Research Plan: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-c-screening
    December 21, 2017 - What are the harms of currently recommended antiviral treatments? * 9.    … 7, and 8 include those defined by age, race/ethnicity, sex, drug use, receipt of maximally assisted therapy … What is the effect of antiviral treatments on behavioral outcomes? … clinical outcomes (KQ 9) Populations Persons with HCV infection being treated with antiviral therapy … behavioral health care; subpopulations of interest include drug use, persons using medication-assisted therapies

11. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening-adults
    December 21, 2023 - (i.e., what percentage of men initially choose active surveillance or watchful waiting vs. curative treatments … such as surgery, radiation, or ablative therapy)?     … (external beam radiation therapy, proton beam therapy, and brachytherapy) Cryosurgery/high-intensity … focused ultrasonography/other focal ablative therapies Active surveillance ‡ Watchful waiting ‡ … ‡Active surveillance and watchful waiting are typically compared to more active treatments in trials.

12. Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/mf27sR5jgcrqcaY9t8d8Jt
    April 04, 2022 - For treatment, this article focuses on first-line medical treatments (prostaglandin analogues, β-blockers … Treatment with topical therapy also significantly de- creased risk of glaucoma progression (defined as … medical therapy vs placebo/no treatment in risk of serious adverse events, withdrawal due to adverse … : Effects of new vs older treatments 8 Trials (KQ not addressed in the prior treatment CER) (n = 4113 … A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects

13. Screening for Autism Spectrum Disorder in Young Children: Clinical Summary (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/kQWchAnAnGxbQmpV9Gwo2H
    February 09, 2016 - Treatment and Interventions Treatments for ASD include behavioral, medical, educational, speech/language … , and occupational therapy and complementary and alternative medicine approaches. … Treatments for young children are primarily behavioral interventions, particularly early intensive behavioral

14. Screening for Glaucoma: Clinical Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/_Rx_VGDNq9Dew_25rqJURA
    July 02, 2013 - Treatment The immediate physiologic goal and measure of effect of primary treatment of glaucoma is reduction … Treatments that are effective in reducing intraocular pressure include medications, laser therapy, … However, these treatments have potential harms, and their effectiveness in reducing patient-perceived … accuracy of screening tests, especially in primary care settings, and the benefits of screening or treatment

15. Clinical Summary: Vision Screening in Children Aged 6 Months to 5 Years (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/LSFY2VhFxKToKkvJjYCzn7
    August 30, 2017 - Treatments Primary treatment includes correction of any underlying refractive error with the use of corrective … lenses, occlusion therapy for amblyopia (eye patching, atropine eye drops, or Bangerter occlusion foils … ), or a combination of treatments.

16. Screening for Pancreatic Cancer: A Brief Evidence Update (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/9wzzgJ4jwQ-gLf6vkDPh2T
    February 01, 2004 - A second search used treatment (including chemotherapy and surgery) in place of screening. … Are there new treatments (or new evidence about old treatments) that improve outcomes for people with … European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy … randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy … vs no- adjuvant treatment in resectable pancreatic cancer (ESPAC-1).

17. Archived: Final Evidence Review: Pancreatic Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review80/pancreatic-cancer-screening-2004
    February 15, 2004 - A second search used treatment (including chemotherapy and surgery) in place of screening. … Key Question 3: Are there new treatments (or new evidence about old treatments) that improve outcomes … European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy … randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy … vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).

18. Evidence Summary: Primary Open-Angle Glaucoma: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/primary-open-angle-glaucoma-screening
    May 24, 2022 - For treatment, this article focuses on first-line medical treatments (prostaglandin analogues, β-blockers … Seventeen trials (n = 4665) evaluated medical treatments for OAG vs placebo or no treatment. 56 , 86 … Treatment with topical therapy also significantly decreased risk of glaucoma progression (defined as … between medical therapy vs placebo/no treatment in risk of serious adverse events, withdrawal due to … KQ8: Effects of new vs older treatments 8 Trials (KQ not addressed in the prior treatment CER)

19. U.S. Preventive Services Task Force Issues Final Recommendation Statement: Screening for Glaucoma (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/glaucomabulletin.pdf
    July 09, 2013 - should continue to see their primary care clinician or eye care specialist to determine which tests and treatments … While there are many new treatments for glaucoma, the USPSTF found that there is not enough evidence … on the health care community to conduct critically needed research on effective screening tests and treatments

20. Archived: Final Research Plan: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-may-2014
    March 15, 2013 - Vaccination   KQs 5–8 Education or behavior change counseling Antiviral treatments … for treatment-naive patients (Note: Food and Drug Administration [FDA]-approved treatments include interferon … alpha, lamivudine, adefovir, entecavir, telbivudine, tenofovir) NonFDA-approved antiviral treatments … , combination therapy Comparators KQs 1, 2 No screening   … disease populations; United States and countries with similar HBV prevalence, except for antiviral therapies